Deciphera Pharmaceuticals diskutieren
Deciphera Pharmaceuticals
WKN: A2H48H / Symbol: DCPH / Name: Deciphera Pharmaceuticals / Aktie / Biotechnologie & medizinische Forschung / Small Cap /
23,80 €
-0,85 %
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was upgraded by analysts at Piper Sandler from a "neutral" rating to an "overweight" rating. They now have a $23.00 price target on the stock.
Ratings data for DCPH provided by MarketBeat
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) was upgraded by analysts at Jonestrading from a "hold" rating to a "buy" rating.
Ratings data for DCPH provided by MarketBeat
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its price target raised by analysts at HC Wainwright from $25.00 to $30.00. They now have a "buy" rating on the stock.
Ratings data for DCPH provided by MarketBeat
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $22.00. They now have a "buy" rating on the stock.
Ratings data for DCPH provided by MarketBeat
Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its price target raised by analysts at Stifel Nicolaus from $22.00 to $23.00. They now have a "buy" rating on the stock.
Ratings data for DCPH provided by MarketBeat
Neueste Beiträge
tracktenuous in Discuss Media And Games Invest SE